XML 47 R22.htm IDEA: XBRL DOCUMENT
v3.25.1

SUBSEQUENT EVENTS | 12 Months Ended
--- | ---
Dec. 31, 2024
SUBSEQUENT EVENTS |
SUBSEQUENT EVENTS | NOTE 16 - SUBSEQUENT EVENTS
| a. | Since December 31, 2024, the Company has collected approximately $4.0 million from sales to Pfizer and approximately $2.9 million from sales to Brazil.
| b. | Since December 31, 2024, the Company sold, in the aggregate 1,223,935 shares of Common Stock under the 2023 Sales Agreement. The Company generated gross proceeds equal to approximately $2.5 million in connection with such sales. As a result of such sales, no shares remain available for sale under the 2023 Sales Agreement and the ATM program thereunder is now complete.
| c. | Since December 31, 2024, the Company issued 908,000 shares of Common Stock in connection with the exercise of warrants issued in 2020 generating proceeds equal to approximately $2.1 million from such exercises. The warrants expired on March 11, 2025. Accordingly, as of March 12, 2025, no warrants remain outstanding.
| d. | In January 2025, the Company deregistered Protalix BV in the Netherlands thereby ending its corporate existence.
​

X
- References No definition available. + Details
Name: | us-gaap_SubsequentEventsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/855/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration